Skip to main content
Erschienen in: Endocrine 2/2014

01.11.2014 | Original Article

Evaluation of left ventricle functions by tissue Doppler, strain, and strain rate echocardiography in patients with primary hyperparathyroidism

verfasst von: Didem Ozdemir, Gulhan Yuksel Kalkan, Nihal Akar Bayram, Eda Demir Onal, Reyhan Ersoy, Engin Bozkurt, Bekir Cakir

Erschienen in: Endocrine | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Cardiovascular morbidity and mortality are increased in patients with primary hyperparathyroidism (PHPT). We aimed to evaluate left ventricle systolic and diastolic functions with tissue Doppler imaging (TDI) and strain and strain rate echocardiography in patients with PHPT. Thirty-one patients with PHPT and 29 healthy controls were evaluated with conventional and pulse Doppler echocardiography, TDI and strain and strain rate echocardiography. Myocardial performance index (MPI) was calculated. Strain and peak systolic strain rate in mid and basal segments of lateral, anterior, inferior, and septal walls of left ventricle were determined. TDI showed similar late diastolic myocardial peak velocity in two groups. Peak systolic mitral annular velocity, early diastolic myocardial peak velocity, and ratio of early to late diastolic myocardial peak velocity were lower in PHPT patients (p = 0.01, p < 0.001 and p < 0.001, respectively). MPI calculated by TDI was 0.53 ± 0.15 in PHPT group and 0.44 ± 0.09 in control group (p = 0.013). Strain values were lower in mid and basal segments of septum, lateral and anterior walls, and basal segment of inferior wall in PHPT patients. Mean systolic strain was −20.88 ± 2.30 and −24.25 ± 2.13 in PHPT patients and control group, respectively (p < 0.001). Mean strain rate was lower in PHPT patients compared to control group (−1.38 ± 0.19 vs −1.57 ± 0.25) (p = 0.002). Patients with PHPT, but no cardiac symptoms or documented cardiovascular disease, have subclinical systolic and diastolic myocardial dysfunction. Evaluation of these patients with TDI and S and Sr echocardiography in addition to conventional echocardiography might be valuable to detect subclinical cardiac involvement.
Literatur
1.
Zurück zum Zitat S.J. Marx, Hyperparathyroid and hypoparathyroid disorders. N. Engl. J. Med. 343, 1863–1875 (2000)PubMedCrossRef S.J. Marx, Hyperparathyroid and hypoparathyroid disorders. N. Engl. J. Med. 343, 1863–1875 (2000)PubMedCrossRef
2.
Zurück zum Zitat G. Hedbäck, A. Odén, Increased risk of death from primary hyperparathyroidism–an update. Eur. J. Clin. Invest. 28(4), 271–276 (1998)PubMedCrossRef G. Hedbäck, A. Odén, Increased risk of death from primary hyperparathyroidism–an update. Eur. J. Clin. Invest. 28(4), 271–276 (1998)PubMedCrossRef
3.
Zurück zum Zitat I.L. Nilsson, L. Yin, E. Lundgren, J. Rastad, A. Ekbom, Clinical presentation of primary hyperparathyroidism in Europe–nationwide cohort analysis on mortality from nonmalignant causes. J. Bone Miner. Res. 17(Suppl 2), N68–N74 (2002)PubMed I.L. Nilsson, L. Yin, E. Lundgren, J. Rastad, A. Ekbom, Clinical presentation of primary hyperparathyroidism in Europe–nationwide cohort analysis on mortality from nonmalignant causes. J. Bone Miner. Res. 17(Suppl 2), N68–N74 (2002)PubMed
4.
Zurück zum Zitat K.D. Schlüter, M. Weber, H.M. Piper, Parathyroid hormone induces protein kinase C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein kinase C-dependent phosphodiesterase activity. Biochem. J. 310(Pt 2), 439–444 (1995)PubMedPubMedCentral K.D. Schlüter, M. Weber, H.M. Piper, Parathyroid hormone induces protein kinase C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein kinase C-dependent phosphodiesterase activity. Biochem. J. 310(Pt 2), 439–444 (1995)PubMedPubMedCentral
5.
Zurück zum Zitat E. Hagström, P. Hellman, T.E. Larsson, E. Ingelsson, L. Berglund, J. Sundström, H. Melhus, C. Held, L. Lind, K. Michaëlsson, J. Arnlöv, Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119(21), 2765–2771 (2009)PubMedCrossRef E. Hagström, P. Hellman, T.E. Larsson, E. Ingelsson, L. Berglund, J. Sundström, H. Melhus, C. Held, L. Lind, K. Michaëlsson, J. Arnlöv, Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119(21), 2765–2771 (2009)PubMedCrossRef
6.
Zurück zum Zitat P.J. Buizert, N.M. van Schoor, S. Simsek, P. Lips, A.C. Heijboer, M. den Heijer, D.J. Deeg, E.M. Eekhoff, PTH: a new target in arteriosclerosis? J. Clin. Endocrinol. Metab. 98(10), E1583–E1590 (2013)PubMedCrossRef P.J. Buizert, N.M. van Schoor, S. Simsek, P. Lips, A.C. Heijboer, M. den Heijer, D.J. Deeg, E.M. Eekhoff, PTH: a new target in arteriosclerosis? J. Clin. Endocrinol. Metab. 98(10), E1583–E1590 (2013)PubMedCrossRef
7.
Zurück zum Zitat K. Dalberg, L.A. Brodin, A. Juhlin-Dannfelt, L.O. Farnebo, Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study. Eur. J. Surg. 162(3), 171–176 (1996)PubMed K. Dalberg, L.A. Brodin, A. Juhlin-Dannfelt, L.O. Farnebo, Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study. Eur. J. Surg. 162(3), 171–176 (1996)PubMed
8.
Zurück zum Zitat T. Stefenelli, C. Abela, H. Frank, J. Koller-Strametz, S. Globits, J. Bergler-Klein, B. Niederle, Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J. Clin. Endocrinol. Metab. 82(1), 106–112 (1997)PubMedCrossRef T. Stefenelli, C. Abela, H. Frank, J. Koller-Strametz, S. Globits, J. Bergler-Klein, B. Niederle, Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J. Clin. Endocrinol. Metab. 82(1), 106–112 (1997)PubMedCrossRef
9.
Zurück zum Zitat T. Stefenelli, H. Mayr, J. Bergler-Klein, S. Globits, W. Woloszczuk, B. Niederle, Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am. J. Med. 95(2), 197–202 (1993)PubMedCrossRef T. Stefenelli, H. Mayr, J. Bergler-Klein, S. Globits, W. Woloszczuk, B. Niederle, Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am. J. Med. 95(2), 197–202 (1993)PubMedCrossRef
10.
Zurück zum Zitat A. Piovesan, N. Molineri, F. Casasso, I. Emmolo, G. Ugliengo, F. Cesario, G. Borretta, Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin. Endocrinol. (Oxf) 50(3), 321–328 (1999)CrossRef A. Piovesan, N. Molineri, F. Casasso, I. Emmolo, G. Ugliengo, F. Cesario, G. Borretta, Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin. Endocrinol. (Oxf) 50(3), 321–328 (1999)CrossRef
11.
Zurück zum Zitat G. Barletta, M.L. De Feo, R. Del Bene, C. Lazeri, S. Vecchiarino, G. La Villa, M.L. Brandi, F. Franchi, Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 85(5), 1815–1821 (2000)PubMed G. Barletta, M.L. De Feo, R. Del Bene, C. Lazeri, S. Vecchiarino, G. La Villa, M.L. Brandi, F. Franchi, Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 85(5), 1815–1821 (2000)PubMed
12.
Zurück zum Zitat N. Ohara, K. Hiramatsu, S. Shigematsu, Y. Hayashi, F. Ishihara, T. Aizawa, A. Niwa, T. Yamada, K. Hashizume, Effect of parathyroid hormone on left ventricular diastolic function in patients with primary hyperparathyroidism. Miner. Electrolyte Metab. 21(1–3), 63–66 (1995)PubMed N. Ohara, K. Hiramatsu, S. Shigematsu, Y. Hayashi, F. Ishihara, T. Aizawa, A. Niwa, T. Yamada, K. Hashizume, Effect of parathyroid hormone on left ventricular diastolic function in patients with primary hyperparathyroidism. Miner. Electrolyte Metab. 21(1–3), 63–66 (1995)PubMed
13.
Zurück zum Zitat I.L. Nilsson, J. Aberg, J. Rastad, L. Lind, Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism-effects of parathyroidectomy. Surgery 128(6), 895–902 (2000)PubMedCrossRef I.L. Nilsson, J. Aberg, J. Rastad, L. Lind, Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism-effects of parathyroidectomy. Surgery 128(6), 895–902 (2000)PubMedCrossRef
14.
Zurück zum Zitat E. Osto, F. Fallo, M.R. Pelizzo, A. Maddalozzo, N. Sorgato, F. Corbetti, R. Montisci, G. Famoso, R. Bellu, T.F. Lüscher, S. Iliceto, F. Tona, Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy. Circulation 126, 1031–1039 (2012)PubMedCrossRef E. Osto, F. Fallo, M.R. Pelizzo, A. Maddalozzo, N. Sorgato, F. Corbetti, R. Montisci, G. Famoso, R. Bellu, T.F. Lüscher, S. Iliceto, F. Tona, Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy. Circulation 126, 1031–1039 (2012)PubMedCrossRef
15.
Zurück zum Zitat M.J. Garcia, J.D. Thomas, A.L. Klein, New Doppler echocardiographic applications for the study of diastolic function. J. Am. Coll. Cardiol. 32(4), 865–875 (1998)PubMedCrossRef M.J. Garcia, J.D. Thomas, A.L. Klein, New Doppler echocardiographic applications for the study of diastolic function. J. Am. Coll. Cardiol. 32(4), 865–875 (1998)PubMedCrossRef
16.
Zurück zum Zitat F. Weidemann, F. Jamal, G.R. Sutherland, P. Claus, L. Hatle, I. De Scheerder, B. Bijnens, F.E. Rademakers, Myocardial function defined by strain rate and strain during alterations in inotropic states and heart rate. Physiol. Heart. Circ. Physiol 283(2), H792–H799 (2002) F. Weidemann, F. Jamal, G.R. Sutherland, P. Claus, L. Hatle, I. De Scheerder, B. Bijnens, F.E. Rademakers, Myocardial function defined by strain rate and strain during alterations in inotropic states and heart rate. Physiol. Heart. Circ. Physiol 283(2), H792–H799 (2002)
17.
Zurück zum Zitat D. Pelerin, L. Cohen, F. Larrazet, F. Extramiana, S. Witchitz, C. Veyrat, New insights into septal anterior wall motion velocities at end-systole in normal and hypertrophied left ventricles. Eur. J. Echocardiography 4, 108–118 (2003)CrossRef D. Pelerin, L. Cohen, F. Larrazet, F. Extramiana, S. Witchitz, C. Veyrat, New insights into septal anterior wall motion velocities at end-systole in normal and hypertrophied left ventricles. Eur. J. Echocardiography 4, 108–118 (2003)CrossRef
18.
Zurück zum Zitat M. Baykan, C. Erem, T. Erdogan, H.O. Ersöz, O. Gedikli, L. Korkmaz, Assessment of left ventricular diastolic function and the Tei index by tissue Doppler imaging in patients with primary hyperparathyroidism. Clin. Endocrinol. (Oxf) 66(4), 483 (2007) M. Baykan, C. Erem, T. Erdogan, H.O. Ersöz, O. Gedikli, L. Korkmaz, Assessment of left ventricular diastolic function and the Tei index by tissue Doppler imaging in patients with primary hyperparathyroidism. Clin. Endocrinol. (Oxf) 66(4), 483 (2007)
19.
Zurück zum Zitat P. Farahnak, M. Ring, K. Caidahl, L.O. Farnebo, M.J. Eriksson, I.L. Nilsson, Cardiac function in mild primary hyperparathyroidism and the outcome after parathyroidectomy. Eur. J. Endocrinol. 163(3), 461–467 (2010)PubMedCrossRefPubMedCentral P. Farahnak, M. Ring, K. Caidahl, L.O. Farnebo, M.J. Eriksson, I.L. Nilsson, Cardiac function in mild primary hyperparathyroidism and the outcome after parathyroidectomy. Eur. J. Endocrinol. 163(3), 461–467 (2010)PubMedCrossRefPubMedCentral
20.
Zurück zum Zitat M.D. Walker, J.B. Fleischer, M.R. Di Tullio, S. Homma, T. Rundek, E.M. Stein, Cardiac structure and diastolic function in mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 95(5), 2172–2179 (2010)PubMedCrossRefPubMedCentral M.D. Walker, J.B. Fleischer, M.R. Di Tullio, S. Homma, T. Rundek, E.M. Stein, Cardiac structure and diastolic function in mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 95(5), 2172–2179 (2010)PubMedCrossRefPubMedCentral
21.
Zurück zum Zitat J.P. Bilezikian, J.T. Potts Jr., Gel-H. Fuleihan, M. Kleerekoper, R. Neer, M. Peacock, J. Rastad, S.J. Silverberg, R. Udelsman, S.A. Wells Jr., Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J. Bone Miner. Res. 17(suppl 2), N2–N11 (2002) J.P. Bilezikian, J.T. Potts Jr., Gel-H. Fuleihan, M. Kleerekoper, R. Neer, M. Peacock, J. Rastad, S.J. Silverberg, R. Udelsman, S.A. Wells Jr., Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J. Bone Miner. Res. 17(suppl 2), N2–N11 (2002)
22.
Zurück zum Zitat A.S. Pearlman, J.M. Gadrin, R.P. Martin, A.F. Parisi, R.L. Popp, M.A. Quinones, J.G. Stevenson, Guidelines for optimal physician training in echocardiography. Recommendations of the American Society of Echocardiography committee for physician training in echocardiography. Am. J. Cardiol. 60, 158–163 (1987)PubMedCrossRef A.S. Pearlman, J.M. Gadrin, R.P. Martin, A.F. Parisi, R.L. Popp, M.A. Quinones, J.G. Stevenson, Guidelines for optimal physician training in echocardiography. Recommendations of the American Society of Echocardiography committee for physician training in echocardiography. Am. J. Cardiol. 60, 158–163 (1987)PubMedCrossRef
23.
Zurück zum Zitat D. Pelerin, R. Sharma, P. Elliott, C. Veyrat, Tissue Doppler, strain, and strain rate echocardiography for the assessment of left and right systolic ventricular function. Heart 89 (Suppl iii), iii9–iii17 (2003) D. Pelerin, R. Sharma, P. Elliott, C. Veyrat, Tissue Doppler, strain, and strain rate echocardiography for the assessment of left and right systolic ventricular function. Heart 89 (Suppl iii), iii9–iii17 (2003)
24.
Zurück zum Zitat H. Ronni-Sivula, Causes of death in patients previously operated on for primary hyperparathyroidism. Ann. Chir. Gynaecol. 74(1), 13–18 (1985)PubMed H. Ronni-Sivula, Causes of death in patients previously operated on for primary hyperparathyroidism. Ann. Chir. Gynaecol. 74(1), 13–18 (1985)PubMed
25.
Zurück zum Zitat I.L. Nilsson, C. Wadsten, L. Brandt, J. Rastad, A. Ekbom, Mortality in sporadic primary hyperparathyroidism: nationwide cohort study of multiple parathyroid gland disease. Surgery. 136(5), 981–987 (2004)PubMedCrossRef I.L. Nilsson, C. Wadsten, L. Brandt, J. Rastad, A. Ekbom, Mortality in sporadic primary hyperparathyroidism: nationwide cohort study of multiple parathyroid gland disease. Surgery. 136(5), 981–987 (2004)PubMedCrossRef
26.
Zurück zum Zitat B.G. Leifsson, B. Ahrén, Serum calcium and survival in a large health screening program. J. Clin. Endocrinol. Metab. 81(6), 2149–2153 (1996)PubMed B.G. Leifsson, B. Ahrén, Serum calcium and survival in a large health screening program. J. Clin. Endocrinol. Metab. 81(6), 2149–2153 (1996)PubMed
27.
Zurück zum Zitat L. Lind, E. Skarfors, L. Berglund, H. Lithell, S. Ljunghall, Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J. Clin. Epidemiol. 50(8), 967–973 (1996)CrossRef L. Lind, E. Skarfors, L. Berglund, H. Lithell, S. Ljunghall, Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J. Clin. Epidemiol. 50(8), 967–973 (1996)CrossRef
28.
Zurück zum Zitat N. Yu, P.T. Donnan, R.W. Flynn, M.J. Murphy, D. Smith, A. Rudman, G.P. Leese, Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin. Endocrinol. (Oxf) 73(1), 30–34 (2010) N. Yu, P.T. Donnan, R.W. Flynn, M.J. Murphy, D. Smith, A. Rudman, G.P. Leese, Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin. Endocrinol. (Oxf) 73(1), 30–34 (2010)
29.
Zurück zum Zitat M. Procopio, M. Barale, S. Bertaina, S. Sigrist, R. Mazzetti, M. Loiacono, G. Mengozzi, E. Ghigo, M. Maccario, Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms. Endocrine. (2013). [Epub ahead of print] doi:10.1007/s12020-013-0091-z M. Procopio, M. Barale, S. Bertaina, S. Sigrist, R. Mazzetti, M. Loiacono, G. Mengozzi, E. Ghigo, M. Maccario, Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms. Endocrine. (2013). [Epub ahead of print] doi:10.​1007/​s12020-013-0091-z
30.
Zurück zum Zitat M.R. Rubin, S.J. Silverberg, Glucose intolerance and primary hyperparathyroidism: an unresolved relationship. Endocrine 42(2), 231–233 (2012)PubMedCrossRef M.R. Rubin, S.J. Silverberg, Glucose intolerance and primary hyperparathyroidism: an unresolved relationship. Endocrine 42(2), 231–233 (2012)PubMedCrossRef
31.
Zurück zum Zitat D. Han, S. Trooskin, X. Wang, Prevalence of cardiovascular risk factors in male and female patients with primary hyperparathyroidism. J. Endocrinol. Invest. 35(6), 548–552 (2012)PubMed D. Han, S. Trooskin, X. Wang, Prevalence of cardiovascular risk factors in male and female patients with primary hyperparathyroidism. J. Endocrinol. Invest. 35(6), 548–552 (2012)PubMed
32.
Zurück zum Zitat F. Längle, C. Abela, J. Koller-Strametz, M. Mittelböck, J. Bergler-Klein, T. Stefenelli, Primary hyperparathyroidism and the heart: cardiac abnormalities correlated to clinical and biochemical data. World J. Surg. 18(4), 619–624 (1994)PubMedCrossRef F. Längle, C. Abela, J. Koller-Strametz, M. Mittelböck, J. Bergler-Klein, T. Stefenelli, Primary hyperparathyroidism and the heart: cardiac abnormalities correlated to clinical and biochemical data. World J. Surg. 18(4), 619–624 (1994)PubMedCrossRef
33.
Zurück zum Zitat J.L. Anderson, R.C. Vanwoerkom, B.D. Horne, T.L. Bair, H.T. May, D.L. Lappé, J.B. Muhlestein, Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am. Heart J. 162(2), 331–339 (2011)PubMedCrossRef J.L. Anderson, R.C. Vanwoerkom, B.D. Horne, T.L. Bair, H.T. May, D.L. Lappé, J.B. Muhlestein, Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am. Heart J. 162(2), 331–339 (2011)PubMedCrossRef
34.
Zurück zum Zitat X. Liu, R. Xie, S. Liu, Rat parathyroid hormone 1-34 signals through the MEK/ERK pathway to induce cardiac hypertrophy. J. Int. Med. Res. 36(5), 942–950 (2008)PubMedCrossRef X. Liu, R. Xie, S. Liu, Rat parathyroid hormone 1-34 signals through the MEK/ERK pathway to induce cardiac hypertrophy. J. Int. Med. Res. 36(5), 942–950 (2008)PubMedCrossRef
35.
Zurück zum Zitat L. Brunaud, A. Germain, R. Zarnegar, M. Rancier, S. Alrasheedi, C. Caillard, A. Ayav, G. Weryha, E. Mirallie, L. Bresler, Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism. Surgery. 146(6), 1035–1041 (2009)PubMedCrossRef L. Brunaud, A. Germain, R. Zarnegar, M. Rancier, S. Alrasheedi, C. Caillard, A. Ayav, G. Weryha, E. Mirallie, L. Bresler, Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism. Surgery. 146(6), 1035–1041 (2009)PubMedCrossRef
36.
Zurück zum Zitat A. Tomaschitz, E. Ritz, B. Pieske, A. Fahrleitner-Pammer, K. Kienreich, J.H. Horina, C. Drechsler, W. März, M. Ofner, T.R. Pieber, S. Pilz, Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. Cardiovasc. Res. 94(1), 10–19 (2012)PubMedCrossRef A. Tomaschitz, E. Ritz, B. Pieske, A. Fahrleitner-Pammer, K. Kienreich, J.H. Horina, C. Drechsler, W. März, M. Ofner, T.R. Pieber, S. Pilz, Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. Cardiovasc. Res. 94(1), 10–19 (2012)PubMedCrossRef
37.
Zurück zum Zitat A.A. Zia, G. Kamalov, K.P. Newman, J.E. McGee, S.K. Bhattacharya, R.A. Ahokas, Y. Sun, I.C. Gerling, K.T. Weber, From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation. Hypertens. Res. 33(11), 1091–1101 (2010)PubMedCrossRef A.A. Zia, G. Kamalov, K.P. Newman, J.E. McGee, S.K. Bhattacharya, R.A. Ahokas, Y. Sun, I.C. Gerling, K.T. Weber, From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation. Hypertens. Res. 33(11), 1091–1101 (2010)PubMedCrossRef
38.
Zurück zum Zitat G. Kamalov, W. Zhao, A.U. Shahbaz, S.K. Bhattacharya, Y. Sun, I.C. Gerling, K.T. Weber, Temporal responses to intrinsically coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria during aldosteronism. Am. J. Physiol. Heart. Circ. Physiol. 298(2), H385–H394 (2010)PubMedCrossRefPubMedCentral G. Kamalov, W. Zhao, A.U. Shahbaz, S.K. Bhattacharya, Y. Sun, I.C. Gerling, K.T. Weber, Temporal responses to intrinsically coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria during aldosteronism. Am. J. Physiol. Heart. Circ. Physiol. 298(2), H385–H394 (2010)PubMedCrossRefPubMedCentral
39.
Zurück zum Zitat C. Bosworth, M.C. Sachs, D. Duprez, A.N. Hoofnagle, J.H. Ix, D.R. Jacobs Jr, D.S. Siscovick, B. Kestenbaum, I.H. de Boer, Parathyroid hormone and arterial dysfunction in the multi-ethnic study of atherosclerosis. Clin. Endocrinol (Oxf). 79(3), 429–436 (2013)PubMedCrossRefPubMedCentral C. Bosworth, M.C. Sachs, D. Duprez, A.N. Hoofnagle, J.H. Ix, D.R. Jacobs Jr, D.S. Siscovick, B. Kestenbaum, I.H. de Boer, Parathyroid hormone and arterial dysfunction in the multi-ethnic study of atherosclerosis. Clin. Endocrinol (Oxf). 79(3), 429–436 (2013)PubMedCrossRefPubMedCentral
40.
Zurück zum Zitat A. Ekmekci, N. Abaci, O.N. Colak, A. Agayev, N. Aksakal, H. Oflaz, N. Erginel-Unaltuna, Y. Erbil, Endothelial function and endothelial nitric oxide synthase intron 4a/b polymorphism in primary hyperparathyroidism. J. Endocrinol. Invest. 32(7), 611–616 (2009)PubMedCrossRef A. Ekmekci, N. Abaci, O.N. Colak, A. Agayev, N. Aksakal, H. Oflaz, N. Erginel-Unaltuna, Y. Erbil, Endothelial function and endothelial nitric oxide synthase intron 4a/b polymorphism in primary hyperparathyroidism. J. Endocrinol. Invest. 32(7), 611–616 (2009)PubMedCrossRef
41.
Zurück zum Zitat G. Schillaci, G. Pucci, M. Pirro, M. Monacelli, A.M. Scarponi, M.R. Manfredelli, F. Rondelli, N. Avenia, E. Mannarino, Large-artery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism. Atherosclerosis. 218(1), 96–101 (2011)PubMedCrossRef G. Schillaci, G. Pucci, M. Pirro, M. Monacelli, A.M. Scarponi, M.R. Manfredelli, F. Rondelli, N. Avenia, E. Mannarino, Large-artery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism. Atherosclerosis. 218(1), 96–101 (2011)PubMedCrossRef
42.
Zurück zum Zitat V. Nuzzo, L. Tauchmanovà, F. Fonderico, R. Trotta, M.R. Fittipaldi, D. Fontana, Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism. Eur. J. Endocrinol. 147(4), 453–459 (2002)PubMedCrossRef V. Nuzzo, L. Tauchmanovà, F. Fonderico, R. Trotta, M.R. Fittipaldi, D. Fontana, Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism. Eur. J. Endocrinol. 147(4), 453–459 (2002)PubMedCrossRef
43.
Zurück zum Zitat S.A. Camacho, R. Brandes, V.M. Figueredo, M.V. Weiner, Ca2 + transient decline and myocardial relaxation are slowed during low flow ischemia in rat hearts. J. Clin. Invest. 93(3), 951–957 (1994)PubMedCrossRefPubMedCentral S.A. Camacho, R. Brandes, V.M. Figueredo, M.V. Weiner, Ca2 + transient decline and myocardial relaxation are slowed during low flow ischemia in rat hearts. J. Clin. Invest. 93(3), 951–957 (1994)PubMedCrossRefPubMedCentral
44.
Zurück zum Zitat J.A. Lax, A.M. Bermann, T.F. Cianciulli, L.A. Morita, O. Masoli, H.A. Prezioso, Estimation of the ejection fraction in patients with myocardial infarction obtained from the combined index of systolic and diastolic left ventricular function: a new method. J. Am. Soc. Echocardiogr. 13(2), 116–123 (2000)PubMedCrossRef J.A. Lax, A.M. Bermann, T.F. Cianciulli, L.A. Morita, O. Masoli, H.A. Prezioso, Estimation of the ejection fraction in patients with myocardial infarction obtained from the combined index of systolic and diastolic left ventricular function: a new method. J. Am. Soc. Echocardiogr. 13(2), 116–123 (2000)PubMedCrossRef
45.
Zurück zum Zitat C. Tei, New non-invasive index for combined systolic and diastolic ventricular function. J. Cardiol. 26(2), 135–136 (1995)PubMed C. Tei, New non-invasive index for combined systolic and diastolic ventricular function. J. Cardiol. 26(2), 135–136 (1995)PubMed
46.
Zurück zum Zitat L. Ascione, M. De Michele, M. Accadia, S. Rumolo, L. Damiano, A. D’Andrea, P. Guarini, B. Tuccillo, Myocardial global performance index as a predictor of in hospital cardiac events in patients with first myocardial infarction. J. Am. Soc. Echocardiogr. 16(10), 1019–1023 (2003)PubMedCrossRef L. Ascione, M. De Michele, M. Accadia, S. Rumolo, L. Damiano, A. D’Andrea, P. Guarini, B. Tuccillo, Myocardial global performance index as a predictor of in hospital cardiac events in patients with first myocardial infarction. J. Am. Soc. Echocardiogr. 16(10), 1019–1023 (2003)PubMedCrossRef
47.
Zurück zum Zitat T.H. Marwick, Measurement of strain and strain rate by echocardiography: ready for prime time? J. Am. Coll. Cardiol. 47(7), 1313–1327 (2006)PubMedCrossRef T.H. Marwick, Measurement of strain and strain rate by echocardiography: ready for prime time? J. Am. Coll. Cardiol. 47(7), 1313–1327 (2006)PubMedCrossRef
48.
Zurück zum Zitat T. Edvardsen, H. Skulstad, S. Aakhus, S. Urheim, H. Ihlen, Regional myocardial systolic function during acute myocardial ischemia assessed by strain Doppler echocardiography. J. Am. Coll. Cardiol. 37(3), 726–730 (2001)PubMedCrossRef T. Edvardsen, H. Skulstad, S. Aakhus, S. Urheim, H. Ihlen, Regional myocardial systolic function during acute myocardial ischemia assessed by strain Doppler echocardiography. J. Am. Coll. Cardiol. 37(3), 726–730 (2001)PubMedCrossRef
49.
Zurück zum Zitat M.S. Alpaydın, E. Aksakal, M.K. Erol, Z. Simşek, M. Açıkel, S. Arslan, F. Gündoğdu, S. Sevimli, S. Karakelleoğlu, Assessment of regional left ventricular functions by strain and strain rate echocardiography in type II diabetes mellitus patients without microvascular complications. Turk Kardiyol. Dern. Ars. 39(5), 378–384 (2011)PubMedCrossRef M.S. Alpaydın, E. Aksakal, M.K. Erol, Z. Simşek, M. Açıkel, S. Arslan, F. Gündoğdu, S. Sevimli, S. Karakelleoğlu, Assessment of regional left ventricular functions by strain and strain rate echocardiography in type II diabetes mellitus patients without microvascular complications. Turk Kardiyol. Dern. Ars. 39(5), 378–384 (2011)PubMedCrossRef
50.
Zurück zum Zitat L. Ernande, E.R. Rietzschel, C. Bergerot, M.L. De Buyzere, F. Schnell, L. Groisne, M. Ovize, P. Croisille, P. Moulin, T.C. Gillebert, G. Derumeaux, Impaired myocardial radial function in asymptomatic patients with type 2 diabetes mellitus: a speckle-tracking imaging study. J. Am. Soc. Echocardiogr. 23(12), 1266–1272 (2010)PubMedCrossRef L. Ernande, E.R. Rietzschel, C. Bergerot, M.L. De Buyzere, F. Schnell, L. Groisne, M. Ovize, P. Croisille, P. Moulin, T.C. Gillebert, G. Derumeaux, Impaired myocardial radial function in asymptomatic patients with type 2 diabetes mellitus: a speckle-tracking imaging study. J. Am. Soc. Echocardiogr. 23(12), 1266–1272 (2010)PubMedCrossRef
51.
Zurück zum Zitat Y.C. Ku, M.E. Liu, C.S. Ku, T.Y. Liu, S.L. Lin, Relationship between vitamin D deficiency and cardiovascular disease. World J. Cardiol. 5(9), 337–346 (2013)PubMedCrossRefPubMedCentral Y.C. Ku, M.E. Liu, C.S. Ku, T.Y. Liu, S.L. Lin, Relationship between vitamin D deficiency and cardiovascular disease. World J. Cardiol. 5(9), 337–346 (2013)PubMedCrossRefPubMedCentral
52.
Zurück zum Zitat L. Wang, Y. Song, J.E. Manson, S. Pilz, W. März, K. Michaëlsson, A. Lundqvist, S.K. Jassal, Barrett-Connor, C. Zhang, C.B. Eaton, H.T. May, J.L. Anderson, H.D. Sesso, Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ. Cardiovasc. Qual. Outcomes. 5(6), 819–829 (2012)PubMedCrossRefPubMedCentral L. Wang, Y. Song, J.E. Manson, S. Pilz, W. März, K. Michaëlsson, A. Lundqvist, S.K. Jassal, Barrett-Connor, C. Zhang, C.B. Eaton, H.T. May, J.L. Anderson, H.D. Sesso, Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ. Cardiovasc. Qual. Outcomes. 5(6), 819–829 (2012)PubMedCrossRefPubMedCentral
53.
Zurück zum Zitat M.D. Walker, E. Cong, A. Kepley, M.R. Di Tullio, T. Rundek, S. Homma, J.A. Lee, R. Liu, P. Young, C. Zhang, D.J. McMahon, S.J. Silverberg, Association between Serum 25-hydroxyvitamin D level and subclinical cardiovascular disease in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 99(2), 671–680 (2014)PubMedCrossRef M.D. Walker, E. Cong, A. Kepley, M.R. Di Tullio, T. Rundek, S. Homma, J.A. Lee, R. Liu, P. Young, C. Zhang, D.J. McMahon, S.J. Silverberg, Association between Serum 25-hydroxyvitamin D level and subclinical cardiovascular disease in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 99(2), 671–680 (2014)PubMedCrossRef
Metadaten
Titel
Evaluation of left ventricle functions by tissue Doppler, strain, and strain rate echocardiography in patients with primary hyperparathyroidism
verfasst von
Didem Ozdemir
Gulhan Yuksel Kalkan
Nihal Akar Bayram
Eda Demir Onal
Reyhan Ersoy
Engin Bozkurt
Bekir Cakir
Publikationsdatum
01.11.2014
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2014
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0245-7

Weitere Artikel der Ausgabe 2/2014

Endocrine 2/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.